Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial

2020593 citationsJournal Articlehybrid Open Access

Authors

Robert M. Jotte · Rocky Mountain Cancer Centers

Federico Cappuzzo · Azienda Unità Sanitaria Locale Della Romagna

Ihor Vynnychenko · Sumy State University

Daniil Stroyakovskiy · Moscow City Oncology Hospital №62

Delvys Rodríguez‐Abreu · Universidad de Las Palmas de Gran Canaria

Maen Hussein · Sarah Cannon

Ross A. Soo

Abstract

Adding atezolizumab to platinum-based chemotherapy significantly improved PFS in patients with first-line squamous NSCLC; OS was similar between the arms.

Topics & Keywords

Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations Lung Cancer Research Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Thoracic Oncology

Volume 15, Issue 8, pp. 1351-1360

DOI: 10.1016/j.jtho.2020.03.028

Field-Weighted Citation Impact: 34.64